Related references
Note: Only part of the references are listed.Development of a novel homogeneous immunoassay using the engineered luminescent enzyme NanoLuc for the quantification of the mycotoxin fumonisin B1
Tawfiq Alsulami et al.
BIOSENSORS & BIOELECTRONICS (2021)
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection
Susanna K. Elledge et al.
NATURE BIOTECHNOLOGY (2021)
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding
James R. Byrnes et al.
MSPHERE (2020)
A homogeneous bioluminescent immunoassay to probe cellular signaling pathway regulation
Byounghoon (Brian) Hwang et al.
COMMUNICATIONS BIOLOGY (2020)
Estimation of competitive antagonist affinity by the Schild method and from functional inhibition curves using a novel form of the Gaddum equation
Martin Ezechias et al.
TOXICOLOGY (2019)
Antibody-Drug Conjugates (ADC) Against Cancer Stem-Like Cells (CSC) - Is There Still Room for Optimism?
Fabrizio Marcucci et al.
FRONTIERS IN ONCOLOGY (2019)
An in vitro FcRn- dependent transcytosis assay as a screening tool for predictive assessment of nonspecific clearance of antibody therapeutics in humans
Shan Chung et al.
MABS (2019)
Illuminating G-Protein-Coupling Selectivity of GPCRs
Asuka Inoue et al.
CELL (2019)
Luminescence- and Fluorescence-Based Complementation Assays to Screen for GPCR Oligomerization: Current State of the Art
Elise Wouters et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Neonatal Fc Receptor (FcRn): A Misnomer?
Michal Pyzik et al.
FRONTIERS IN IMMUNOLOGY (2019)
Mind the Gap: How Interspecies Variability in IgG and Its Receptors May Complicate Comparisons of Human and Non-human Primate Effector Function
Andrew R. Crowley et al.
FRONTIERS IN IMMUNOLOGY (2019)
Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics
Nicole M. Piche-Nicholas et al.
MABS (2018)
Quantitative interaction analysis permits molecular insights into functional NOX4 NADPH oxidase heterodimer assembly
Sharon O'Neill et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Human and mouse albumin bind their respective neonatal Fc receptors differently
Jeannette Nilsen et al.
SCIENTIFIC REPORTS (2018)
Impact of SPR biosensor assay configuration on antibody: Neonatal Fc receptor binding data
Xiangdan Wang et al.
MABS (2017)
Development of NanoLuc bridging immunoassay for detection of anti-drug antibodies
Nidhi Nath et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2017)
A Two-pronged Binding Mechanism of IgG to the Neonatal Fc Receptor Controls Complex Stability and IgG Serum Half-life
Pernille Foged Jensen et al.
MOLECULAR & CELLULAR PROTEOMICS (2017)
The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study
Peter Kiessling et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
NanoLuc Complementation Reporter Optimized for Accurate Measurement of Protein Interactions in Cells
Andrew S. Dixon et al.
ACS CHEMICAL BIOLOGY (2016)
Enhanced FcRn-dependent transepithelial delivery of IgG by Fc-engineering and polymerization
Stian Foss et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Certolizumab pegol does not bind the neonatal Fc receptor (FcRn): Consequences for FcRn-mediated in vitro transcytosis and ex vivo human placental transfer
Charlene Porter et al.
JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2016)
FcRn: The Architect Behind the Immune and Nonimmune Functions of IgG and Albumin
Michal Pyzik et al.
JOURNAL OF IMMUNOLOGY (2015)
The neonatal Fc receptor (FcRn) binds independently to both sites of the IgG homodimer with identical affinity
Yasmina Noubia Abdiche et al.
MABS (2015)
Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics
Angela Schoch et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Screening Technologies for Small Molecule Discovery: The State of the Art
William P. Janzen
CHEMISTRY & BIOLOGY (2014)
A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies
Jan Stracke et al.
MABS (2014)
Characterization and screening of IgG binding to the neonatal Fc receptor
Tobias Neuber et al.
MABS (2014)
Biacore surface matrix effects on the binding kinetics and affinity of an antigen/antibody complex
Andrew W. Drake et al.
ANALYTICAL BIOCHEMISTRY (2012)
Bimolecular fluorescence complementation (BiFC): A 5-year update and future perspectives
Yutaka Kodama et al.
BIOTECHNIQUES (2012)
Abdegs: an alternative to IVIg?
David Killock
Nature Reviews Rheumatology (2011)
Intravenous immunoglobulins (IVIg) in the treatment of autoimmune diseases
S.-V. KAVERI et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Higher throughput calorimetry: opportunities, approaches and challenges
Francisco E. Torres et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2010)
Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR
Takuo Suzuki et al.
JOURNAL OF IMMUNOLOGY (2010)
Protein complementation assays: Approaches for the in vivo analysis of protein interactions
Montse Morell et al.
FEBS LETTERS (2009)
An in vivo map of the yeast protein interactome
Kirill Tarassov et al.
SCIENCE (2008)
A novel method for determination of the affinity of protein: Protein interactions in homogeneous assays
Philip Newton et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
Taking the time to study competitive antagonism
D. J. A. Wyllie et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Universal strategies in research and drug discovery based on protein-fragment complementation assays
Stephen W. Michnick et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn)
William F. Dall'Acqua et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Engineering the Fc region of immunoglobulin G to modulate in vivo antibody levels
C Vaccaro et al.
NATURE BIOTECHNOLOGY (2005)
Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases
J Bayry et al.
NEUROLOGICAL SCIENCES (2003)
Increasing the affinity of a human IgG1, for the neonatal Fc receptor: Biological consequences
WF Dall'Acqua et al.
JOURNAL OF IMMUNOLOGY (2002)
Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies
RJ Ober et al.
INTERNATIONAL IMMUNOLOGY (2001)
Share Paper
